CD19-specific CAR T cells with a fully human binding domain

CD19-targeted chimeric antigen receptor T-cell (fully human binding domain) · Seattle Children's Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-specific CAR T cells with a fully human binding domain, covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma [Phase 1]

See pricing